Acacia Research Corp Files 8-K on Financials

TL;DR

ACAC filed an 8-K detailing financial results. Check it out.

AI Summary

Acacia Research Corporation filed an 8-K on March 14, 2024, to report on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance. The company is incorporated in Delaware and its principal executive offices are located in New York, NY.

Why It Matters

This filing provides investors with an update on Acacia Research Corporation's financial health and operational results, which can influence investment decisions.

Risk Assessment

Risk Level: low — This is a routine financial filing (8-K) and does not appear to contain any immediately alarming or significant new information.

Key Players & Entities

• ACACIA RESEARCH CORP (company) — Registrant
• March 14, 2024 (date) — Filing Date
• Delaware (jurisdiction) — State of Incorporation
• New York, NY (location) — Principal Executive Offices

FAQ

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 per share ACTG The Nasdaq Stock Market
• $20 million — mpany to purchase up to an aggregate of $20 million of the Company's common stock subject,

Filing Documents

• actg-20240314.htm (8-K) — 27KB
• actg-20231231xex991.htm (EX-99.1) — 202KB
• logoa.jpg (GRAPHIC) — 29KB
• 0000934549-24-000019.txt ( ) — 405KB
• actg-20240314.xsd (EX-101.SCH) — 2KB
• actg-20240314_lab.xml (EX-101.LAB) — 22KB
• actg-20240314_pre.xml (EX-101.PRE) — 13KB
• actg-20240314_htm.xml (XML) — 3KB

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On March 14, 2024, Acacia Research Corporation (the "Corporation) issued a press release announcing its financial results for the year ended December 31, 2023. A copy of that release is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this "Report"). The information contained within this Report and the exhibit attached hereto as Exhibit 99.1 are being furnished pursuant to Item 2.02 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in this Report and the exhibit attached hereto as Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, regardless of any general incorporation by reference language in such filings, except as shall be expressly set forth by specific reference in such filing.

01. Other Events

Item 8.01. Other Events. On November 9, 2023, the Board of Directors (the "Board") of Acacia Research Corporation (the "Company") approved a stock repurchase program authorizing the Company to purchase up to an aggregate of $20 million of the Company's common stock subject, to a cap of 5,800,000 shares of common stock. The repurchase authorization has no time limit and does not require the repurchase of a minimum number of shares. The common stock may be repurchased on the open market, in block trades, or in privately negotiated transactions, including under plans complying with the provisions of Rule 10b5-1 and Rule 10b-18 of the Exchange Act.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description of Exhibit 99.1 Press Release dated March 1 4 , 202 4 of Acacia Research Corporation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: March 14, 2024 ACACIA RESEARCH CORPORATION By: /s/ Martin D. McNulty Jr. Name: Martin D. McNulty Jr. Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR